Carolyn C. Tang, General Counsel at Arcus Biosciences, Inc. (RCUS), sold 1,109 shares at $40.46 ($44K) on 2021-12-16, disclosed to the SEC on 2021-12-20.
Open-market sale of $44k RCUS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.59 | 356 | $14K | 31.7% |
| 2 | $40.46 | 131 | $5K | 11.9% |
| 3 | $38.79 | 138 | $5K | 12.0% |
| 4 | $39.67 | 88 | $3K | 7.8% |
| 5 | $40.57 | 171 | $7K | 15.6% |
| 6 | $41.42 | 225 |
| $9K |
| 20.9% |
| Total | $40.12 avg | 1,109 | $44K | 100% |
| Filing → |
| RCUS | SELL | 2022-06-21 | $63K | — | Filing → |
| RCUS | SELL | 2021-06-21 | $70K | — | Filing → |